Tenvir‑EM 300 mg/200 mg (Tenofovir + Emtricitabine Tablets)
Price range: $150 through $440Tenvir‑EM 300 mg/200 mg (Tenofovir + Emtricitabine Tablets) offers a fixed-dose combination used both for HIV‑1 treatment and as pre-exposure prophylaxis (PrEP) in at‑risk individuals. Tenofovir disoproxil fumarate and emtricitabine work synergistically to suppress viral replication and reduce risk of infection in HIV‑negative users, providing convenient once‑daily oral therapy under medical supervision.

